Muus P - Search Results

1

Regulation of the expression of mitochondrial proteins: relationship between mtDNA copy number and cytochrome-c oxidase activity in human cells and tissues.

Van den Bogert C, De Vries H, Holtrop M, Muus P, Dekker HL, Van Galen MJ, Bolhuis PA, Taanman JW. Van den Bogert C, et al. Among authors: muus p. Biochim Biophys Acta. 1993 Sep 13;1144(2):177-83. doi: 10.1016/0005-2728(93)90170-k. Biochim Biophys Acta. 1993. PMID: 8396443

2

1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.

Muus P, Van den Bogert C, De Vries H, Pennings A, Holtrop M, Haanen C. Muus P, et al. Br J Cancer. 1991 Jul;64(1):29-34. doi: 10.1038/bjc.1991.234. Br J Cancer. 1991. PMID: 1649619 Free PMC article.

3

Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells.

Van den Bogert C, Muus P, Haanen C, Pennings A, Melis TE, Kroon AM. Van den Bogert C, et al. Among authors: muus p. Exp Cell Res. 1988 Sep;178(1):143-53. doi: 10.1016/0014-4827(88)90385-0. Exp Cell Res. 1988. PMID: 3409975

4

Influence of cytarabine on mitochondrial function and mitochondrial biogenesis.

Muus P, Haanen C, Pennings A, Ruitenbeek W, Van den Bogert C. Muus P, et al. Semin Oncol. 1987 Jun;14(2 Suppl 1):245-50. Semin Oncol. 1987. PMID: 3035719

5

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Brons PP, Haanen C, Boezeman JB, Muus P, Holdrinet RS, Pennings AH, Wessels HM, de Witte T. Brons PP, et al. Among authors: muus p. Ann Hematol. 1993 May;66(5):225-33. doi: 10.1007/BF01738470. Ann Hematol. 1993. PMID: 8507717

6

Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.

Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C. Van Der Lely N, et al. Among authors: muus p. Exp Hematol. 1991 May;19(4):267-72. Exp Hematol. 1991. PMID: 2055291

7

The effect of cytosine arabinoside upon mitochondrial staining kinetics in human hematopoietic cells.

Haanen C, Muus P, Pennings A. Haanen C, et al. Among authors: muus p. Histochemistry. 1986;84(4-6):609-13. doi: 10.1007/BF00482999. Histochemistry. 1986. PMID: 3487533

8

GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.

De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J. De Witte T, et al. Among authors: muus p. Behring Inst Mitt. 1988 Aug;(83):301-7. Behring Inst Mitt. 1988. PMID: 3071344

9

Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: muus p. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:33-5. Bone Marrow Transplant. 1989. PMID: 2697396 Clinical Trial.

10

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

De Witte T, Muus P, De Pauw B, Haanen C. De Witte T, et al. Among authors: muus p. Cancer. 1990 Sep 1;66(5):831-7. doi: 10.1002/1097-0142(19900901)66:5<831::aid-cncr2820660503>3.0.co;2-e. Cancer. 1990. PMID: 2386911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters